Loading...
01/10 15:53
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed outlook. Positive elements include record revenue growth, international expansion, and product innovation. However, these are counterbalanced by an EPS miss, tariff impacts, and potential risks from municipal funding and contract delays. The Q&A section reveals positive sentiment towards product pipelines and international opportunities, but management's unclear responses on certain topics raise concerns. The share repurchase is a positive signal, yet the financial health is mixed with improved revenue but a net loss. Overall, the stock price is likely to remain stable, resulting in a 'Neutral' sentiment.
Revenue $28.3 million, a 12% increase from $25.4 million in Q1 2024, driven by solid new sales and renewal activity, including $3.5 million of catch-up revenue from delayed contracts with NYPD.
Adjusted EBITDA $4.5 million, a 50% increase from $3 million in Q1 2024, attributed to operational leverage and the impact of the delayed contracts.
Gross Profit $16.6 million, 59% of revenue, consistent with the prior year period's gross profit of $14.9 million, also 59% of revenue.
GAAP Net Loss $1.5 million, or $0.12 per share, improved from a net loss of $2.9 million, or $0.23 per share in Q1 2024, due to improved revenue and cost management.
Cash and Cash Equivalents $11.7 million, down from $13.2 million at the end of Q4 2024, but significantly higher than $5.7 million at the end of 2023.
Deferred Revenue $45.4 million, slightly up from $44.2 million at the end of Q4 2024, indicating stable contract renewals.
Operating Expenses $17.8 million, or 63% of revenue, compared to $17.5 million, or 69% of revenue in Q1 2024, showing improved efficiency.
Share Repurchase 33,493 shares repurchased at an average price of $15.04 for approximately $504,000 in Q1 2025.
CrimeTracer: CrimeTracer is evolving into a powerful AI-enhanced law enforcement tool, allowing investigators to perform natural language queries for actionable insights.
SafePointe: SafePointe is positioned to meet new California legislation requiring weapon detection systems in hospitals by 2027, with significant market potential.
ResourceRouter: ResourceRouter is a proactive patrol planning tool, now deployed in over 20 agencies, helping allocate officer resources effectively.
International Expansion: ShotSpotter is set to deploy in Niteroi, Brazil, marking a return to the Latin American market and expanding its international footprint.
Chicago RFP: ShotSpotter submitted a bid for a 5-year gunshot detection contract in Chicago, with expectations of a strong proposal.
Revenue Growth: Q1 2025 revenue grew 12% year-over-year to $28.3 million, aided by contract renewals with NYPD.
Adjusted EBITDA: Adjusted EBITDA increased 50% year-over-year to $4.5 million, reflecting operational leverage.
Growth Strategy: The company reaffirms its revenue guidance of $111 million to $113 million for 2025, despite headwinds from municipal funding.
AI Investments: Investments in AI modeling and tools are being made to enhance product offerings and operational efficiency.
Earnings Miss: ShotSpotter, Inc. reported an EPS of $-0.12, missing expectations of $-0.06.
Regulatory Challenges: California Assembly Bill 2975 mandates hospitals to deploy weapon detection systems by 2027, creating a significant opportunity but also a compliance challenge for healthcare facilities.
Municipal Funding Risks: The company remains vigilant about headwinds related to municipal funding and budgets, which could impact sales and contract renewals.
Tariff Impact: The company has slightly reduced its adjusted EBITDA guidance due to the modest impact of the current tariff regime.
Attrition Risk: ShotSpotter is modeling higher levels of attrition than historically experienced to account for potential volatility in customer retention.
Contract Delays: The company experienced delayed contract renewals, which impacted revenue recognition and financial performance.
Investment Costs: Increased investments in AI modeling and tools are expected to affect the adjusted EBITDA margin.
Revenue Growth: 12% revenue growth year-over-year to $28.3 million, driven by solid new sales and renewal activity.
NYPD Contract Renewal: NYPD extended their ShotSpotter contract for an additional three years, valued at $64 million over a 3-year term.
International Expansion: Deployment in Niteroi, Brazil, with expectations for accelerated international traction in the second half of 2025.
CrimeTracer Development: Integration of generative AI to enhance data insights for law enforcement, improving investigative capabilities.
ResourceRouter Adoption: ResourceRouter deployed in over 20 agencies, doubling its installed base in less than 18 months.
SafePointe Growth Opportunity: California Assembly Bill 2975 mandates weapon detection systems in hospitals by 2027, creating significant market potential.
Full Year Revenue Guidance: Reaffirming revenue guidance range of $111 million to $113 million for 2025.
Adjusted EBITDA Margin Guidance: Reducing adjusted EBITDA margin guidance to 20% to 22% due to tariff impacts and AI investments.
Annual Recurring Revenue (ARR) Guidance: Expecting ARR to increase from $95.6 million at the beginning of 2025 to approximately $110 million at the beginning of 2026.
Share Repurchase: Repurchased 33,493 shares at an average price of $15.04 for approximately $504,000 in the first quarter of 2025.
The earnings call reveals a mix of positive and negative factors. While there is optimism about new product launches, market expansion, and AI investments, there are concerns about delayed deals, gross margin declines, and conservative guidance. The Q&A highlights unresolved issues, such as the CrimeTracer deal and Puerto Rico renewal, which contribute to uncertainty. Overall, the sentiment is balanced, leading to a neutral prediction.
The earnings call presents a mixed picture: while revenue grew by 12%, the GAAP net loss widened significantly. The international expansion and SafePointe opportunities are promising, but the decrease in deferred revenue and cash reserves is concerning. The Q&A reveals optimism in market opportunities and competitive positioning, but management's vague responses on key projects like the Chicago RFP and sniper threat solution add uncertainty. The reaffirmed revenue guidance is positive, but reduced EBITDA margin guidance and cash flow concerns balance out the outlook, leading to a neutral stock price prediction.
The earnings call presents a mixed outlook. Positive elements include record revenue growth, international expansion, and product innovation. However, these are counterbalanced by an EPS miss, tariff impacts, and potential risks from municipal funding and contract delays. The Q&A section reveals positive sentiment towards product pipelines and international opportunities, but management's unclear responses on certain topics raise concerns. The share repurchase is a positive signal, yet the financial health is mixed with improved revenue but a net loss. Overall, the stock price is likely to remain stable, resulting in a 'Neutral' sentiment.
The earnings call presents a mixed picture. While there is strong revenue growth, product innovation, and strategic partnerships, concerns arise from reduced EBITDA guidance, regulatory issues, and competitive pressures. The Q&A reveals a solid pipeline but highlights uncertainties in international expansion and contract discussions. The share repurchase is a positive signal, but the lack of clear guidance on key issues tempers enthusiasm. Overall, the combination of positive and negative factors suggests a neutral stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
